| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e559743173473475142b7bd8a978298 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d880bd53219daed9a333f7018189e06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceb7bf09f30892af69481ef73e781ce9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea68dca9358818a694c33e7f58f1eabd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cdce090a7ffb126041a5a1c65edb23d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56385a09d6cb81f4d8320955fda3d569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0004078040a79766f8156027f694fc91 |
| publicationDate |
2013-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0716302-A2 |
| titleOfInvention |
Interval Time Delayed Oral Pharmaceutical Composition and Method for Preparing an Interval Time Delayed Oral Oral Pharmaceutical Composition |
| abstract |
"Delayed ORAL DELAYED PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING AN INTERVAL DELAYED ORAL RELEASE PHARMACEUTICAL COMPOSITION". Disclosed herein is a pharmaceutical composition containing a thiazide compound and an angiotensin-II receptor blocker, and a technology for formulating them. More specifically, a pharmaceutical combination formulation of the thiazide compound and angiotensin-II receptor blocker is disclosed which maximizes clinical pharmacological and antihypertensive effects and complication preventive effects of drugs and reduces side effects of drugs in particular. compared to single component formulations of medicinal products that are administered simultaneously. |
| priorityDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |